According to DonaldJTrumpJr, US political leaders including HHS Secretary Robert Kennedy Jr. and Republican Governors are initiating efforts to address corruption in the Pharmacy Benefit Manager (PBM) industry to reduce drug prices for Americans (source: nytimes.com, June 10, 2025, via Twitter). This policy shift could trigger significant volatility in pharmaceutical stocks, particularly for companies with high PBM exposure. Crypto traders should monitor these regulatory changes, as healthcare sector turbulence often drives investors toward digital assets like BTC and ETH as alternative hedges during periods of market uncertainty.